FDA approves First-of-its-kind pill to lower cholesterol
Digest more
The FDA has approved Lipfendra (enlicitide), the first oral PCSK9 inhibitor, for adult hypercholesterolemia and HeFH.
After finding out you have hypercholesterolemia, your medical team may recommend medication to lower your high cholesterol levels and thus reduce your risk of heart attack, stroke, and other ...
New York, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Hypercholesterolemia Drugs in Development by Stages, Target, MoA ...
Strong Buy on oncology pipeline gains and LIPFENDRA launch, with KEYTRUDA patent risks. Click for this MRK update.
High "bad" cholesterol, or hypercholesterolemia, affects about 10% of adults in the United States and about 7% of youth, according to government statistics. Genetics are one major reason for high ...
NEW ORLEANS, LA—Bad news for devotees of popular “Keto” low-carb, high-fat (LCHF) diets: a prospective analysis confirms that this eating pattern is associated with significant increases in LDL ...
Hypercholesterolemia: All You Need To Know About It And 5 Foods To Manage The Condition Hypercholesterolemia is a condition characterised by the presence of very high levels of cholesterol in the ...
We describe a series of cases of extreme hypercholesterolemia mediated by lipoprotein X in patients with chronic graft-versus-host disease of the liver after an allogeneic bone marrow transplant.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results